GENERATION OF EFFICACY, TOXICITY AND DISEASE SIGNATURES AND METHODS OF USE THEREOF

Details for Australian Patent Application No. 2003303199 (hide)

Owner CANTATA PHARMACEUTICALS, INC.

Inventors ROGERS, James, Anthony; ROSENBERG, Alexander, Frederic; WIEGAND, Roger, Charles; MCCARROLL, Robert, Michael; LI, Lily, Y., T.; WEI, Dong; CROSAS, Merce

Pub. Number AU-A-2003303199

PCT Number PCT/US2003/0407

PCT Pub. Number WO2004/056456

Priority 10/323,493 18.12.02 US

Filing date 18 December 2003

Wipo publication date 14 July 2004

International Classifications

B01D 059/44 Separation of different isotopes of the same chemical element

C12Q 001/00 Measuring or testing processes involving enzymes or micro-organisms

G01N 001/00 Sampling

G01N 024/00 Investigating or analysing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects

Event Publications

12 August 2004 Complete Application Filed

  Priority application(s): 10/323,493 18.12.02 US

19 August 2004 Application Open to Public Inspection

  Published as AU-A-2003303199

22 September 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003303200-LIGHTED WAND ASSEMBLY

2003303198-METHOD FOR TREATING AMYLOID DISEASE